La Jolla, CA, United States of America

Andrew Trinin Dennis

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Andrew Trinin Dennis in Analyte Sensing

Introduction

Andrew Trinin Dennis, an accomplished inventor based in La Jolla, CA, has made significant strides in the field of biosensing technology. With a focus on developing devices that determine analyte concentrations, his work has garnered attention within the medical and technology communities.

Latest Patents

Andrew Trinin Dennis holds two patents that reflect his innovative contributions to analyte sensing. The first patent involves an analyte sensor designed to determine concentration levels. This device includes a sensor that generates a signal correlated to the analyte concentration, paired with an electronics unit connected to the sensor. This unit can be secured to a host’s skin via a housing, which may be affixed through an adhesive patch.

The second patent focuses on membrane layers for analyte sensors, specifically for determining glucose levels. This invention also consists of a sensor creating a signal linked to the analyte concentration, covered by a sensing membrane. This membrane features a biointerface layer that interacts with biological fluid, incorporating biointerface polymers such as polyurethane and polyurea segments. Additionally, it includes an enzyme layer and a diffusion-resistance layer crafted from a base polymer for enhanced performance.

Career Highlights

Andrew is currently affiliated with Dexcom, Inc., a leader in continuous glucose monitoring technology. His work has been instrumental in advancing the way individuals monitor glucose levels, providing both healthcare professionals and patients with critical data for managing diabetes.

Collaborations

While working at Dexcom, Andrew has collaborated with talented colleagues, including Shanger Wang and Ted Tang Lee. These partnerships have enabled him to push the boundaries of innovation in biosensing technology.

Conclusion

Andrew Trinin Dennis exemplifies the spirit of innovation within the field of analyte sensing. With his groundbreaking patents and collaborative efforts at Dexcom, he continues to contribute to advancements that significantly improve patient care and health monitoring.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…